ESC-HFA 2024: Late-Breaking Science Video Collection

Published: 14 May 2024

  • Views:

    Views Icon 1067

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Discover the latest heart failure data from impactful trials and studies presented at the Heart Failure Association’s annual congress, Heart Failure 2024. 

Dive deep into novel data with in-depth and critical discussions led by Late-breaker host Dr Harriette Van Spall and her expert guests. 

For quick and practical summaries of the late-breaking trials, watch our 5-minute Expert Interviews conducted with the investigators.

More from this programme

Part 1

Late-breaker Discussions with Dr Van Spall

Thought-provoking discussions with the investigators.
4 sessions
HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie Watch now
Late-Breaker Discussion: The TITRATE-HF Study Watch now
Late-Breaker Discussion: Insights from the STEP-HFpEF Watch now
Late-Breaker Discussion: Findings from PACT-HF Watch now

Part 2

Expert Interviews

Short, practical interviews with the investigators.
8 sessions
Remote Patient Monitoring for Patients With Heart Failure: TELESAT Watch now
Cordella PA Sensor System in NYHA Class III HF Patients: PROACTIVE-HF Watch now
Aspirin Avoidance after Implantation of a Fully Magnetically Levitated LVAD: ARIES HM3 Watch now
Timing of Cardio-Kidney Protection with SGLT2i Watch now
Treatment Benefit Consistency of Remote Hemodynamic Monitoring in CHF: MONITOR-HF Subgroup Analysis Watch now
Inter-Atrial Shunt Treatment to Reduce Lung Congestion in Patients with Advanced Heart Failure: RELIEVE-HF Watch now
FINE-HEART: Design & Baseline Characteristics Watch now
HFA 24: The RELIEVE-HF Trial: Differential Effects of V-Wave Device Watch now

About the episode

Investigator, Prof Nicolas Girerd (University Hospital of Nancy, FR) joins us to discuss the findings from the TELESAT study (NCT06312501).

This multicenter observational longitudinal cohort study investigated whether a Remote Patient Monitoring (RPM) program (Satelia®Cardio, Satelia) is able to prevent cardiac decompensation by detecting weak signals of decompensation early in patients with chronic heart failure in France. The study enrolled 20,000 participants with heart failure, with the primary outcome being all-cause death from August 2018 to December 2021.

Findings showed an association between RPM programmes and lower all-cause mortality (35% reduction) based on weight and symptoms evaluation coupled with tele-education. 

Interview Questions:

  1. What was the reasoning behind this trial?
  2. What was the patient population and study design?
  3. What were the key results revealed at HFA 24?
  4. How should these findings impact practice and future research?
  5. What surprised you about the results of TELESAT study?

Recorded on-site at HFA 2024, Lisbon. 

Faculty Biographies

Nicolas Girerd

View full profile

Comments

You must be to comment. If you are not registered, you can register here.